CurrentEndo
Get Weekly

Topic · page 108 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 4,281–4,320 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetologia

    Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study

    Cohort study

  2. JAMA

    Cardiovascular Risk Factor Prevalence, Treatment, and Control in US Adults Aged 20 to 44 Years, 2009 to March 2020

    Cross-sectional study

  3. Cardiovasc Diabetol

    CT-derived fractional flow reserve for prediction of major adverse cardiovascular events in diabetic patients

    Cohort study

  4. Diabetes Obes Metab

    iGlarLixi (insulin glargine 100 U / ml plus lixisenatide) is effective and well tolerated in people with uncontrolled type 2 diabetes regardless of age: A REALI pooled analysis of prospective real‐world data

    Meta-analysis

  5. Cardiovasc Diabetol

    Prognostic implication of stress hyperglycemia in patients with acute coronary syndrome undergoing percutaneous coronary intervention

    Cohort study

  6. Diabetes Res Clin Pract

    Low-density lipoprotein cholesterol levels are associated with first-phase insulin release

    Cross-sectional study

  7. Diabetes Res Clin Pract

    Circulating levels of gastrointestinal hormones in prediabetes reversing to normoglycemia or progressing to diabetes in a year–A cross-sectional and prospective analysis

    Cross-sectional study

  8. Diabetes Care

    Earlier Age at Type 2 Diabetes Diagnosis Is Associated With Increased Genetic Risk of Cardiovascular Disease

    Cohort study

  9. J Clin Endocrinol Metab

    Reproducibility of Glycemic Measures Among Dysglycemic Youth and Adults in the RISE Study

    Secondary analysis

  10. Cardiovasc Diabetol

    Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials

    Meta-analysis

  11. Diabetes Care

    CRP, C-Peptide, and Risk of First-Time Cardiovascular Events and Mortality in Early Type 2 Diabetes: A Danish Cohort Study

    Cohort study

  12. BMJ Open Diabetes Res Care

    Association between tea consumption and glucose metabolism and insulin secretion in the Shanghai High-risk Diabetic Screen (SHiDS) study

    Cross-sectional study

  13. Diabetes Res Clin Pract

    Association between antidiabetic drugs and the incidence of atrial fibrillation in patients with type 2 diabetes: A nationwide cohort study in South Korea

    Cohort study

  14. Diabetes Metab

    Association between glycemic status and age-related macular degeneration: A nationwide population-based cohort study

    Cohort study

  15. Diabet Med

    Cost‐effectiveness of a multicomponent quality improvement care model for diabetes in South Asia: The CARRS randomized clinical trial

    Randomized controlled trial

  16. Diabet Med

    Diabetes distress mediates the relationship between depressive symptoms and glycaemic control among adults with type 2 diabetes: Findings from a multi‐site diabetes peer support intervention

    Secondary analysis

  17. Diabetes Metab

    Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study

    Cohort study

  18. Diabetes Res Clin Pract

    Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: A model-based cost-effectiveness analysis using real-world data

    Research article

  19. Diabetes Obes Metab

    Allometric body shape indices, type 2 diabetes and kidney function: A two‐sample Mendelian randomization study

    Research article

  20. J Clin Endocrinol Metab

    Efficacy and Safety of Low-dose Spironolactone for Chronic Kidney Disease in Type 2 Diabetes

    Randomized controlled trial

  21. J Clin Endocrinol Metab

    Expression of Neurotensin and Its Receptors Along the Intestinal Tract in Type 2 Diabetes Patients and Healthy Controls

    Mechanistic study

  22. J Clin Endocrinol Metab

    The Prevalence of Metabolically Unhealthy Normal Weight and Its Influence on the Risk of Diabetes

    Cohort study

  23. Diabetologia

    Upregulated TGF-β1 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling

    Mechanistic study

  24. Cardiovasc Diabetol

    Neutral effects of SGLT2 inhibitors in acute coronary syndromes, peripheral arterial occlusive disease, or ischemic stroke: a meta-analysis of randomized controlled trials

    Meta-analysis

  25. Nat Med

    Optimal dietary patterns for prevention of chronic disease

    Cohort study

  26. Diabetes Res Clin Pract

    Sodium-glucose cotransporter-2 inhibitors and cancer outcomes: A systematic review and meta-analysis of randomized controlled trials

    Meta-analysis

  27. Diabetes Obes Metab

    Albuminuria‐lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross‐over clinical study

    Randomized controlled trial

  28. Cardiovasc Diabetol

    Association of the triglyceride–glucose index with coronary artery disease complexity in patients with acute coronary syndrome

    Cross-sectional study

  29. Diabetes Obes Metab

    Once‐weekly semaglutide use in patients with type 2 diabetes: Real‐world data from the SURE Italy observational study

    Cohort study

  30. Cardiovasc Diabetol

    Association of diabetes mellitus and glycemic control with left ventricular function and deformation in patients after acute myocardial infarction: a 3 T cardiac magnetic resonance study

    Cross-sectional study

  31. Diabetes Care

    Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis

    Secondary analysis

  32. J Clin Endocrinol Metab

    Preserved Ratio Impaired Spirometry, Metabolomics, and the Risk of Type 2 Diabetes

    Cohort study

  33. Cardiovasc Diabetol

    Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients

    Case-control study

  34. Cardiovasc Diabetol

    Cardiovascular outcomes with SGLT2 inhibitors versus DPP4 inhibitors and GLP-1 receptor agonists in patients with heart failure with reduced and preserved ejection fraction

    Cohort study

  35. Cardiovasc Diabetol

    General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial

    Secondary analysis

  36. Cardiovasc Diabetol

    Associations of genetic markers of diabetes mellitus with carotid atherosclerosis: a community-based case–control study

    Research article

  37. Cardiovasc Diabetol

    The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetes

    Randomized controlled trial

  38. Cardiovasc Diabetol

    Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes

    Meta-analysis

  39. Diabetes Metab

    Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study

    Randomized controlled trial

  40. Diabetes Obes Metab

    Real‐world impact of once‐weekly subcutaneous semaglutide after 2 years of follow‐up: Results from a nationwide observational study in people with type 2 diabetes

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 4,281–4,320 of 4,758, newest first